series-c-plus
Stage
1
Investors
About
Zealand Pharma is a biotechnology company that discovers and develops peptide-based medicines focused on metabolic diseases such as obesity and rare diseases including congenital hyperinsulinism and short bowel syndrome.
Explore Zealand Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.